4//SEC Filing
Hermelin David S 4
Accession 0001277161-12-000003
CIK 0000057055other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 3:29 PM ET
Size
5.1 KB
Accession
0001277161-12-000003
Insider Transaction Report
Form 4
Hermelin David S
DirectorVice PresidentOther
Transactions
- Award
Option to Purchase
2012-05-14+20,000→ 20,000 totalExercise: $0.94Exp: 2022-05-14→ Class A Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option vests 33% on May 14, 2013, 33% on May 14, 2014 and 34% on May 15, 2015.
Documents
Issuer
KV PHARMACEUTICAL CO /DE/
CIK 0000057055
Entity typeother
Related Parties
1- filerCIK 0001296276
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 3:29 PM ET
- Size
- 5.1 KB